Fraunhofer Institute for Cell Therapy and Immunology IZI

We transfer biomedical research into the clinic.

The Fraunhofer Institute for Cell Therapy and Immunology IZI investigates and develops solutions to specific problems at the interfaces of medicine, life sciences and engineering. One of the institute‘s main tasks is to conduct contract research for companies, hospitals, diagnostic laboratories and research institutes operating in the field of biotechnology, pharma­ceuticals and medical engineering.

The Fraunhofer IZI develops, optimizes and validates methods, materials and products within the business fields cell and gene therapy, drugs and vaccines, molecular diagnostics and immunodiagnostics, as well as extracorporeal therapies. Its areas of competence lie in cell biology, immunology, drug biochemistry, bioanalytics and bioproduction as well as process development and automation. Research in these areas is centered around developments in immuno-oncology and infectious disease pathology. The S3 safety laboratory allows research and development activities to be conducted and highly pathogenic agents investigated under biosafety level 3 conditions.

The institute works in close cooperation with hospital institutions and performs quality tests besides manufacturing investigational medicinal products in line with GMP requirements. Furthermore, it supports partners in developing processes for the pharmaceutical production of ATMPs and biologicals, for example by helping them to obtain manufacturing licenses.


Latest press releases


Fraunhofer IZI and Nomad Bioscience extend and broaden collaboration

The Fraunhofer Institute for Cell Therapy and Immunology IZI and Nomad Bioscience GmbH have extended and expanded their collaboration. In July 2020, both had concluded an initial research and development agreement. The Fraunhofer IZI Molecular Drug Biochemistry and Therapeutics Development Branch in Halle (Saale) supports the Munich-based company in the identification and preclinical development of pharmaceutical product candidates, in particular through assay development, pharmacological and toxicological studies, and the development of preclinical models.
Read more


Outstanding bachelor thesis awarded

Lukas Nöltner, a student at Biberach University of Applied Sciences, was honored for his bachelor's thesis on "Characterization of monoclonal antibodies against the HERV Fc1 envelope protein", which was written at the Fraunhofer Institute for Cell Therapy and Immunology IZI. Biberach University of Applied Sciences honors students for outstanding achievements twice a year. The 500 euro prize in the field of pharmaceutical biotechnology was sponsored by the company Boehringer Ingelheim.
Read more


Researchers want to filter and inactivate airborne pathogens using tissue

Researchers at the Fraunhofer Institute for Cell Therapy and Immunology are working on developing a tissue that can be used to filter and inactivate airborne pathogens. On November 11, 2021, the project team from Leipzig received a funding commitment from the Else Kröner-Fresenius Stiftung (EKFS) for the "Aerocatch" project.
Read more


Anhalt University of Applied Sciences and Fraunhofer IZI open joint research laboratory for natural product-based therapeutics

Are algae the superfood and active ingredient suppliers of the future? Under the direction of Professor Carola Griehl, researchers at the Competence Center Algal Biotechnology at Anhalt University of Applied Sciences have been working on this question for many years. On May 27, 2021 the Anhalt University of Applied Sciences and the Fraunhofer Institute for Cell Therapy and Immunology IZI open the Center for Natural Product-Based Therapeutics (ZNT). In addition to the invited guests on site, all interested parties are invited via live stream to the ceremonial opening.
Read more

Press / media


As an institution of application-oriented research, the Fraunhofer Institute for Cell Therapy and Immunology IZI attaches great importance to informing customers and the public.



The Fraunhofer IZI offers its partners and guests space for communication.

Utilize our modern and representative premises for your event. The generously proportioned and modern space offered at the Institute provides space for, e. g., workshops, symposia, conferences and lectures.



Fraunhofer Prize for “Human- and Environment-Centered Technology” 2021

For a vaccine production process that is faster, more efficient and more environmentally friendly.


November 9-10, 2021 | Virtual conference

Leipzig Immune ONcology Conference (LION)

The LION Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology.


United against Corona


Annual report 2020

The annual report gives you an insight into the structure of the Fraunhofer IZI, our services, important events and publications, offers, as well as selected project examples.

Research projects funded by the EU

Research projects at Fraunhofer IZI that are supported by the Land of Saxony / Saxony-Anhalt / Mecklenburg-Western Pomerania using funds provided by the European Regional Development Fund (ERDF).


Business units and core competencies

The Fraunhofer IZI offers R&D services for pharmaceutical, biotechnological and medical technology companies as well as for partners from research institutions, hospitals and diagnostic laboratories.

Jobs / career

We keep you informed on current job offers at the Fraunhofer IZI. Find out about the possibilities the Fraunhofer-Gesellschaft could offer you as an employer.


We gladly provide our clients and partners as well as the interested public with information on our research activities.



Fraunhofer IZI


Perlickstraße 1
04103 Leipzig

Phone +49 341 35536-1000
Fax +49 341 35536-8-1000


Social Media